W Wang, M Zhao, L Cui, Y Ren, J Zhang, J Chen, L Jia… - Molecular cancer, 2020 - Springer
Background Cisplatin is a first-line drug for the treatment of human non-small cell lung
cancer (NSCLC); however, the majority of patients will develop drug resistance after …